Search

everythinglearnresearchcommunity

for

Search:↓

The JAK/STAT pathway is important in cell processes and disease, and JAK inhibitors are promising for treating related conditions.

IL-17 inhibitors for psoriasis may cause unexpected hair loss.

New treatments for alopecia areata show promise, but more research is needed to confirm their effectiveness.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Using low-dose IL-2 to increase regulatory T cells might be a safe way to treat type 1 diabetes without severe side effects.

Genetically modified stem cells from human hair follicles can lower blood sugar and increase survival in diabetic mice.

Infliximab may cause hair loss in Crohn's disease patients.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Human skin can provide stem cells for tissue repair and regeneration, but there are challenges in obtaining and growing these cells safely.

Oxidative stress plays a significant role in alopecia areata, and new treatments may include JAK inhibitors and antioxidants.

New regenerative treatments for hair loss show promise but need more research for confirmation.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Mesenchymal stem cells could help treat radiation-induced bladder damage but more research is needed to overcome current limitations.

Innate lymphoid cells help control skin bacteria by regulating sebaceous glands.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

SLE patients with Evans syndrome often show blood issues and need careful monitoring and treatment.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Tigers had a skin condition causing hair loss and inflammation, but the cause is unknown and treatment didn't work.

Foreign-body granuloma may be a marker for late-stage Lichen Planopilaris and should be considered in diagnosis.

A 9-year-old girl with alopecia areata had successful hair regrowth using bimatoprost after other treatments failed.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Drugs targeting the JAK/STAT pathway can improve atopic dermatitis but vary in effectiveness for vitiligo and alopecia areata, with generally mild safety concerns.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Some patients receiving pegylated interferon alfa injections developed skin necrosis, requiring treatment adjustments or discontinuation.